CB&I Announces Technology Contract From GS Caltex Corporation

        CB&I Announces Technology Contract From GS Caltex Corporation

PR Newswire

THE WOODLANDS, Texas, Oct. 17, 2013

THE WOODLANDS, Texas, Oct. 17, 2013 /PRNewswire/ -- CB&I (NYSE: CBI) announced
today it has been awarded a contract by GS Caltex Corporation for the license,
basic engineering and catalyst supply for a new paraxylene unit to be built in
Yeosu, Korea.

The unit will use the BP paraxylene technology, exclusively licensed by CB&I,
and will have a world scale design capacity. Start-up is expected in 2016.

The technology employs an innovative energy-efficient crystallization process
to produce paraxylene and will provide GS Caltex with a reliable, low cost
solution for its world scale plant.

"The energy efficiency and operating cost benefits afforded by this proven
crystallization-based paraxylene technology are very attractive to the
industry as evidenced by this latest award," said Daniel McCarthy, Executive
Vice President and President of CB&I's Technology operating group. "The
technology is employed in BP's operating units and has proven to be robust and
reliable."

Paraxylene is an intermediate in the manufacture of polyester, a polymer used
for a variety of applications from fibers to engineering plastics.

About CB&I
CB&I (NYSE:CBI) is the most complete energy infrastructure focused company in
the world and a major provider of government services. Drawing upon more than
a century of experience and the expertise of approximately 50,000 employees,
CB&I provides reliable solutions while maintaining a relentless focus on
safety and an uncompromising standard of quality. For more information, visit
www.cbi.com.

Important Information For Investors And Shareholders

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements regarding CB&I and
represents our expectations and beliefs concerning future events. These
forward-looking statements are intended to be covered by the safe harbor for
forward-looking statements provided by the Private Securities Litigation
Reform Act of 1995. Forward-looking statements involve known and unknown risks
and uncertainties. When considering any statements that are predictive in
nature, depend upon or refer to future events or conditions, or use or contain
words, terms, phrases or expressions such as "achieve," "forecast," "plan,"
"propose," "strategy," "envision," "hope," "will," "continue," "potential,"
"expect," "believe," "anticipate," "project," "estimate," "predict," "intend,"
"should," "could," "may," "might" or similar forward-looking statements, we
refer you to the cautionary statements concerning risk factors and
"Forward-Looking Statements" described under "Risk Factors" in Item 1A of our
Annual Report filed on Form 10-K filed with the SEC for the year ended
December 31, 2012, and any updates to those risk factors or "Forward-Looking
Statements" included in our subsequent Quarterly Reports on Form 10-Q filed
with the SEC, which cautionary statements are incorporated herein by
reference.

(Logo: http://photos.prnewswire.com/prnh/20130430/DA04155LOGO)

SOURCE CB&I

Website: http://www.cbi.com
Contact: Media: www.CBI.com; Or Investors: Christi Thoms +1 832 513 1200
 
Press spacebar to pause and continue. Press esc to stop.